High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients

Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men

(2008) Richard Marsell et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

(2008) G. Jean et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Evidence for Persistent Vitamin D 1-Alpha-Hydroxylation in Hemodialysis Patients: Evolution of Serum 1,25-Dihydroxycholecalciferol after 6 Months of 25-Hydroxycholecalciferol Treatment

(2008) G. Jean et al.   NEPHRON CLINICAL PRACTICE

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

(2008) Orlando M. Gutiérrez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function

(2007) Marcel Roos et al.   CLINICAL ENDOCRINOLOGY

Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients

(2007) P. Urena Torres et al.   KIDNEY INTERNATIONAL